| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000084 | Mitotic s phase | Affects phenotype | PMID:30981936; PMID:33839396 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Affects phenotype | PMID:33839396 |
| GO:0000278 | Mitotic cell cycle | Affects phenotype | PMID:30981936 |
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:33839396; PMID:34830855 |
| GO:0001774 | Microglial cell activation | Increases phenotype | PMID:33839396 |
| GO:0001780 | Neutrophil homeostasis | Affects phenotype | PMID:31226429; PMID:31807802; PMID:33524429 |
| GO:0001836 | Release of cytochrome c from mitochondria | Increases phenotype | PMID:29859868 |
| GO:0001979 | Regulation of systemic arterial blood pressure by chemoreceptor signaling | Increases phenotype | PMID:29471072 |
| GO:0002009 | Morphogenesis of an epithelium | Affects phenotype | PMID:25643018 |
| GO:0002286 | T cell activation involved in immune response | Increases phenotype | PMID:33524429 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:25233897; PMID:34060014; PMID:39419344 |
| GO:0002638 | Negative regulation of immunoglobulin production | Increases phenotype | PMID:29667781 |
| GO:0002686 | Negative regulation of leukocyte migration | Increases phenotype | PMID:29667781 |
| GO:0003014 | Renal system process | Affects phenotype | PMID:34200920 |
| GO:0003016 | Respiratory system process | Decreases phenotype | PMID:31981688 |
| GO:0003019 | Central nervous system control of baroreceptor feedback | Increases phenotype | PMID:29471072 |
| GO:0003025 | Regulation of systemic arterial blood pressure by baroreceptor feedback | Increases phenotype | PMID:29471072 |
| GO:0003990 | Acetylcholinesterase activity | Decreases phenotype | PMID:26519479; PMID:29939342 |
| GO:0003993 | Acid phosphatase activity | Decreases phenotype | PMID:34678318 |
| GO:0004035 | Alkaline phosphatase activity | Affects phenotype | PMID:32955216; PMID:33908150; PMID:34678318 |
| GO:0004064 | Arylesterase activity | Increases phenotype | PMID:24979751; PMID:34425170; PMID:36058312 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:32955216; PMID:33524429; PMID:33908150 |
| GO:0004104 | Cholinesterase activity | Decreases phenotype | PMID:29097212; PMID:29729306; PMID:29736246; PMID:29736246; PMID:30035273; PMID:30035273; PMID:35358535; PMID:30656380; PMID:35225412; PMID:34200920; PMID:35358535 |
| GO:0004364 | Glutathione transferase activity | Decreases phenotype | PMID:27268782; PMID:28373059; PMID:30267645; PMID:34425170; PMID:34678318; PMID:34678318; PMID:38522820 |
| GO:0004457 | Lactate dehydrogenase activity | Affects phenotype | PMID:23364943; PMID:34678318 |
| GO:0004602 | Glutathione peroxidase activity | Affects phenotype | PMID:25233897; PMID:28373059; PMID:28373059; PMID:30497708; PMID:29108776; PMID:30267645; PMID:30497708; PMID:32120800; PMID:32602772; PMID:33908150; PMID:33908150; PMID:38849050; PMID:34678318; PMID:38849050; PMID:39419344 |
| GO:0004784 | Superoxide dismutase activity | Affects phenotype | PMID:25233897; PMID:28373059; PMID:28373059; PMID:30497708; PMID:35448458; PMID:29108776; PMID:30267645; PMID:30497708; PMID:30758894; PMID:32120800; PMID:32602772; PMID:32955216; PMID:33908150; PMID:33908150; PMID:38849050; PMID:34678318; PMID:38849050; PMID:39419344 |
| GO:0004935 | Adrenergic receptor activity | Increases phenotype | PMID:26419632 |
| GO:0005391 | P-type sodium:potassium-exchanging transporter activity | Decreases phenotype | PMID:29736246 |
| GO:0006006 | Glucose metabolic process | Affects phenotype | PMID:32745781; PMID:39419344 |
| GO:0006083 | Acetate metabolic process | Affects phenotype | PMID:32745781 |
| GO:0006089 | Lactate metabolic process | Affects phenotype | PMID:34259569 |
| GO:0006105 | Succinate metabolic process | Affects phenotype | PMID:32745781 |
| GO:0006117 | Acetaldehyde metabolic process | Affects phenotype | PMID:34830855 |
| GO:0006121 | Mitochondrial electron transport, succinate to ubiquinone | Decreases phenotype | PMID:36269219 |
| GO:0006122 | Mitochondrial electron transport, ubiquinol to cytochrome c | Decreases phenotype | PMID:36269219 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:27941166; PMID:29359425; PMID:33078895 |
| GO:0006537 | Glutamate biosynthetic process | Increases phenotype | PMID:29665406 |
| GO:0006568 | Tryptophan metabolic process | Affects phenotype | PMID:34259569 |
| GO:0006580 | Ethanolamine metabolic process | Affects phenotype | PMID:36858108 |
| GO:0006631 | Fatty acid metabolic process | Affects phenotype | PMID:28433638; PMID:32745781 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:27760213; PMID:39419344 |
| GO:0006693 | Prostaglandin metabolic process | Affects phenotype | PMID:34424684 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:26257840; PMID:27268782; PMID:27268782; PMID:33908150; PMID:29667781; PMID:29859868; PMID:31823260; PMID:32651842; PMID:33586219; PMID:33586219; PMID:34678318; PMID:33908150; PMID:34425170; PMID:34425170; PMID:39419344; PMID:34678318; PMID:36058312; PMID:36811218; PMID:39419344 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:23850137; PMID:24979751; PMID:28373059; PMID:30267645 |
| GO:0006805 | Xenobiotic metabolic process | Affects phenotype | PMID:24283477 |
| GO:0006809 | Nitric oxide biosynthetic process | Increases phenotype | PMID:28373059 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:26187449 |
| GO:0006915 | Apoptotic process | Affects phenotype | PMID:14976342; PMID:24793810; PMID:26435000; PMID:26519479; PMID:28549829; PMID:30378422; PMID:30497708; PMID:30758894; PMID:30835941; PMID:32096903; PMID:35457321; PMID:36252918 |
| GO:0006919 | Activation of cysteine-type endopeptidase activity involved in apoptotic process | Increases phenotype | PMID:26198043; PMID:27737797 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:23416140; PMID:31807802; PMID:33586219; PMID:33908150 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:29859868; PMID:30981936; PMID:33908150 |
| GO:0006979 | Response to oxidative stress | Affects phenotype | PMID:31400774 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:32955216 |
| GO:0007197 | Adenylate cyclase-inhibiting g protein-coupled acetylcholine receptor signaling pathway | Increases phenotype | PMID:36058312 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:23172834; PMID:34678318 |
| GO:0007601 | Visual perception | Affects phenotype | PMID:27773359 |
| GO:0007610 | Behavior | Affects phenotype | PMID:27773359; PMID:32057829 |
| GO:0007612 | Learning | Increases phenotype | PMID:30656380; PMID:32387648 |
| GO:0007613 | Memory | Decreases phenotype | PMID:27773359; PMID:30497708; PMID:36811218 |
| GO:0007631 | Feeding behavior | Increases phenotype | PMID:31226429; PMID:31472362 |
| GO:0008088 | Axo-dendritic transport | Decreases phenotype | PMID:25614231 |
| GO:0008152 | Metabolic process | Affects phenotype | PMID:32179266 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:32745781; PMID:39419344 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:32440878; PMID:32440878; PMID:36769379; PMID:36769379 |
| GO:0008219 | Cell death | Increases phenotype | PMID:19589100; PMID:23994500; PMID:24979751; PMID:26210949; PMID:27163631; PMID:29665406 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:24793810; PMID:25137620; PMID:26018426; PMID:26514924; PMID:30236991; PMID:32736067; PMID:34424684; PMID:34424684; PMID:39832751; PMID:34830855; PMID:35457321 |
| GO:0008284 | Positive regulation of cell population proliferation | Affects phenotype | PMID:26079056; PMID:26257840; PMID:31136966; PMID:32171938 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:24215065; PMID:26198043; PMID:29555536; PMID:32651842; PMID:32800223; PMID:32949729; PMID:33078895 |
| GO:0008291 | Acetylcholine metabolic process | Affects phenotype | PMID:33930485 |
| GO:0008344 | Adult locomotory behavior | Affects phenotype | PMID:30267645 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:30378422 |
| GO:0008635 | Activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c | Affects phenotype | PMID:23416140 |
| GO:0008652 | Amino acid biosynthetic process | Affects phenotype | PMID:28433638 |
| GO:0009448 | Gamma-aminobutyric acid metabolic process | Affects phenotype | PMID:34259569 |
| GO:0010459 | Negative regulation of heart rate | Increases phenotype | PMID:29471072 |
| GO:0010507 | Negative regulation of autophagy | Increases phenotype | PMID:35439518 |
| GO:0010508 | Positive regulation of autophagy | Increases phenotype | PMID:34289071 |
| GO:0010637 | Negative regulation of mitochondrial fusion | Increases phenotype | PMID:28112198 |
| GO:0010718 | Positive regulation of epithelial to mesenchymal transition | Increases phenotype | PMID:32956863 |
| GO:0010917 | Negative regulation of mitochondrial membrane potential | Increases phenotype | PMID:28112198 |
| GO:0010918 | Positive regulation of mitochondrial membrane potential | Decreases phenotype | PMID:26070385 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:23416140; PMID:26299976; PMID:29893964; PMID:40434365 |
| GO:0010976 | Positive regulation of neuron projection development | Increases phenotype | PMID:28385489 |
| GO:0010977 | Negative regulation of neuron projection development | Increases phenotype | PMID:28369648 |
| GO:0014002 | Astrocyte development | Increases phenotype | PMID:33011216 |
| GO:0014054 | Positive regulation of gamma-aminobutyric acid secretion | Increases phenotype | PMID:28975519 |
| GO:0014721 | Twitch skeletal muscle contraction | Increases phenotype | PMID:31879696 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:27163631; PMID:28373059; PMID:30267645; PMID:30497708; PMID:30497708; PMID:32006337; PMID:30758894; PMID:31226429; PMID:32006337; PMID:32096903; PMID:32096903; PMID:33908150; PMID:32120800; PMID:32955216; PMID:33586219; PMID:33586219; PMID:34678318; PMID:33908150; PMID:33930485; PMID:34425170; PMID:34678318 |
| GO:0016049 | Cell growth | Affects phenotype | PMID:28887667; PMID:29665406; PMID:30236991 |
| GO:0016209 | Antioxidant activity | Decreases phenotype | PMID:26519479 |
| GO:0016887 | Atp hydrolysis activity | Decreases phenotype | PMID:32006337; PMID:34425170 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:30990955; PMID:31400774 |
| GO:0019226 | Transmission of nerve impulse | Decreases phenotype | PMID:38599286 |
| GO:0019369 | Arachidonic acid metabolic process | Affects phenotype | PMID:33900070 |
| GO:0019627 | Urea metabolic process | Affects phenotype | PMID:27268782; PMID:32745781; PMID:33908150; PMID:33908150; PMID:38849050; PMID:38849050; PMID:39419344 |
| GO:0019915 | Lipid storage | Increases phenotype | PMID:28291828 |
| GO:0022402 | Cell cycle process | Increases phenotype | PMID:26514924 |
| GO:0030262 | Apoptotic nuclear changes | Increases phenotype | PMID:31136966 |
| GO:0030263 | Apoptotic chromosome condensation | Affects phenotype | PMID:31981688; PMID:33586219 |
| GO:0030317 | Flagellated sperm motility | Decreases phenotype | PMID:34678318 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:32800223; PMID:32956863 |
| GO:0030899 | Calcium-dependent atpase activity | Decreases phenotype | PMID:29736246; PMID:35439518 |
| GO:0031324 | Negative regulation of cellular metabolic process | Increases phenotype | PMID:30765052; PMID:36058312 |
| GO:0031987 | Locomotion involved in locomotory behavior | Increases phenotype | PMID:29803855; PMID:29859868; PMID:30267645; PMID:31618664; PMID:32736067 |
| GO:0032024 | Positive regulation of insulin secretion | Increases phenotype | PMID:32685429 |
| GO:0032148 | Activation of protein kinase b activity | Decreases phenotype | PMID:36058312 |
| GO:0032811 | Negative regulation of epinephrine secretion | Increases phenotype | PMID:31400786 |
| GO:0034263 | Positive regulation of autophagy in response to er overload | Increases phenotype | PMID:34289071 |
| GO:0034275 | Kynurenic acid metabolic process | Affects phenotype | PMID:34259569 |
| GO:0034377 | Plasma lipoprotein particle assembly | Increases phenotype | PMID:31400774; PMID:32179266 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:23172834; PMID:23172834; PMID:31823260; PMID:25233897; PMID:26257840; PMID:27268782; PMID:27941166; PMID:29667781; PMID:31823260; PMID:39419344 |
| GO:0035176 | Social behavior | Increases phenotype | PMID:30823929; PMID:36113784; PMID:36796608; PMID:31472362; PMID:32179266; PMID:32736067; PMID:32976529 |
| GO:0035640 | Exploration behavior | Affects phenotype | PMID:29859868; PMID:31472362 |
| GO:0035702 | Monocyte homeostasis | Affects phenotype | PMID:31226429; PMID:33524429 |
| GO:0035882 | Defecation rhythm | Affects phenotype | PMID:30267645 |
| GO:0035937 | Estrogen secretion | Affects phenotype | PMID:35457321 |
| GO:0036126 | Sperm flagellum | Affects phenotype | PMID:34678318 |
| GO:0036145 | Dendritic cell homeostasis | Affects phenotype | PMID:33900070 |
| GO:0036343 | Psychomotor behavior | Decreases phenotype | PMID:26297601 |
| GO:0036483 | Neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | Increases phenotype | PMID:34289071 |
| GO:0040011 | Locomotion | Decreases phenotype | PMID:32387648 |
| GO:0040018 | Positive regulation of multicellular organism growth | Decreases phenotype | PMID:25643018 |
| GO:0042053 | Regulation of dopamine metabolic process | Decreases phenotype | PMID:26297601 |
| GO:0042100 | B cell proliferation | Increases phenotype | PMID:32120800 |
| GO:0042403 | Thyroid hormone metabolic process | Affects phenotype | PMID:34571837 |
| GO:0042417 | Dopamine metabolic process | Affects phenotype | PMID:29859868; PMID:32006337 |
| GO:0042421 | Norepinephrine biosynthetic process | Increases phenotype | PMID:21453761; PMID:26419632 |
| GO:0042428 | Serotonin metabolic process | Affects phenotype | PMID:32006337 |
| GO:0042448 | Progesterone metabolic process | Affects phenotype | PMID:32440878 |
| GO:0042541 | Hemoglobin biosynthetic process | Decreases phenotype | PMID:27905518 |
| GO:0042554 | Superoxide anion generation | Increases phenotype | PMID:29859868; PMID:30981936; PMID:33839396 |
| GO:0042593 | Glucose homeostasis | Decreases phenotype | PMID:29097212; PMID:31400774; PMID:32685429 |
| GO:0042632 | Cholesterol homeostasis | Decreases phenotype | PMID:31400774; PMID:32685429 |
| GO:0042743 | Hydrogen peroxide metabolic process | Affects phenotype | PMID:27268782; PMID:33930485 |
| GO:0043029 | T cell homeostasis | Affects phenotype | PMID:31807802; PMID:33524429 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:23416140; PMID:26070385; PMID:26070385; PMID:36058312; PMID:29893964; PMID:31823260; PMID:32800223 |
| GO:0043249 | Erythrocyte maturation | Decreases phenotype | PMID:27905518 |
| GO:0043525 | Positive regulation of neuron apoptotic process | Increases phenotype | PMID:34289071; PMID:35439518 |
| GO:0044237 | Cellular metabolic process | Increases phenotype | PMID:29859868; PMID:30378422; PMID:30758894; PMID:30835941; PMID:31152760; PMID:32017950; PMID:32120800; PMID:32798940; PMID:33839396; PMID:33930485; PMID:34259569; PMID:34352351; PMID:34678318; PMID:35457321; PMID:36252918 |
| GO:0044403 | Biological process involved in symbiotic interaction | Affects phenotype | PMID:31622728 |
| GO:0045217 | Cell-cell junction maintenance | Decreases phenotype | PMID:36167171 |
| GO:0045333 | Cellular respiration | Decreases phenotype | PMID:29859868; PMID:34528356 |
| GO:0045428 | Regulation of nitric oxide biosynthetic process | Affects phenotype | PMID:32526215 |
| GO:0045429 | Positive regulation of nitric oxide biosynthetic process | Increases phenotype | PMID:31823260 |
| GO:0045444 | Fat cell differentiation | Increases phenotype | PMID:28291828; PMID:32017950 |
| GO:0045454 | Cell redox homeostasis | Decreases phenotype | PMID:31823260; PMID:35439518 |
| GO:0045687 | Positive regulation of glial cell differentiation | Decreases phenotype | PMID:27816694 |
| GO:0045727 | Positive regulation of translation | Increases phenotype | PMID:35137321 |
| GO:0045766 | Positive regulation of angiogenesis | Increases phenotype | PMID:32526215 |
| GO:0045776 | Negative regulation of blood pressure | Increases phenotype | PMID:29471072 |
| GO:0045777 | Positive regulation of blood pressure | Increases phenotype | PMID:29471072 |
| GO:0045919 | Positive regulation of cytolysis | Increases phenotype | PMID:27941166; PMID:31400774 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Affects phenotype | PMID:21987380; PMID:26198043; PMID:29893964 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:29859868; PMID:32949729; PMID:35448458; PMID:35457321 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:27268782; PMID:27268782; PMID:38849050; PMID:32006337; PMID:34425170; PMID:34425170; PMID:39419344; PMID:34678318; PMID:38042398; PMID:38849050 |
| GO:0046330 | Positive regulation of jnk cascade | Affects phenotype | PMID:23416140 |
| GO:0046415 | Urate metabolic process | Decreases phenotype | PMID:32715474 |
| GO:0046449 | Creatinine metabolic process | Decreases phenotype | PMID:27268782; PMID:32715474; PMID:33908150; PMID:33908150; PMID:38849050; PMID:39419344; PMID:38849050; PMID:39419344 |
| GO:0046459 | Short-chain fatty acid metabolic process | Affects phenotype | PMID:27760213; PMID:31622728 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:26519479; PMID:35439518; PMID:36152060 |
| GO:0046498 | S-adenosylhomocysteine metabolic process | Affects phenotype | PMID:34259569 |
| GO:0046500 | S-adenosylmethionine metabolic process | Affects phenotype | PMID:34259569 |
| GO:0046541 | Saliva secretion | Increases phenotype | PMID:31981688 |
| GO:0046621 | Negative regulation of organ growth | Increases phenotype | PMID:31823260 |
| GO:0046655 | Folic acid metabolic process | Affects phenotype | PMID:34259569 |
| GO:0046683 | Response to organophosphorus | Affects phenotype | PMID:31981688 |
| GO:0048149 | Behavioral response to ethanol | Affects phenotype | PMID:24849677 |
| GO:0048266 | Behavioral response to pain | Increases phenotype | PMID:26409647 |
| GO:0048621 | Post-embryonic digestive tract morphogenesis | Affects phenotype | PMID:25643018 |
| GO:0048666 | Neuron development | Increases phenotype | PMID:33011216 |
| GO:0048675 | Axon extension | Decreases phenotype | PMID:18076960 |
| GO:0048874 | Host-mediated regulation of intestinal microbiota composition | Increases phenotype | PMID:31400786 |
| GO:0050665 | Hydrogen peroxide biosynthetic process | Increases phenotype | PMID:27163631; PMID:28373059; PMID:30267645 |
| GO:0050769 | Positive regulation of neurogenesis | Increases phenotype | PMID:28112198 |
| GO:0050808 | Synapse organization | Decreases phenotype | PMID:33011216 |
| GO:0050872 | White fat cell differentiation | Increases phenotype | PMID:32745781 |
| GO:0050890 | Cognition | Decreases phenotype | PMID:27773359; PMID:33540251 |
| GO:0050995 | Negative regulation of lipid catabolic process | Increases phenotype | PMID:38522820 |
| GO:0051092 | Positive regulation of nf-kappab transcription factor activity | Increases phenotype | PMID:30978295 |
| GO:0051301 | Cell division | Decreases phenotype | PMID:34425170 |
| GO:0051318 | G1 phase | Affects phenotype | PMID:30378422 |
| GO:0051319 | G2 phase | Decreases phenotype | PMID:30378422 |
| GO:0051320 | S phase | Affects phenotype | PMID:30378422 |
| GO:0051345 | Positive regulation of hydrolase activity | Increases phenotype | PMID:36058312 |
| GO:0051346 | Negative regulation of hydrolase activity | Affects phenotype | PMID:29097212 |
| GO:0051560 | Mitochondrial calcium ion homeostasis | Increases phenotype | PMID:26435000 |
| GO:0051602 | Response to electrical stimulus | Affects phenotype | PMID:26409647 |
| GO:0051726 | Regulation of cell cycle | Affects phenotype | PMID:30378422 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:26435000; PMID:29859868; PMID:30981936; PMID:32798940 |
| GO:0051882 | Mitochondrial depolarization | Increases phenotype | PMID:29859868 |
| GO:0052689 | Carboxylic ester hydrolase activity | Increases phenotype | PMID:29097212; PMID:29935250; PMID:33900070; PMID:35151815 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:30056177; PMID:34425170 |
| GO:0060004 | Reflex | Affects phenotype | PMID:32976529 |
| GO:0060011 | Sertoli cell proliferation | Decreases phenotype | PMID:38522820 |
| GO:0060018 | Astrocyte fate commitment | Increases phenotype | PMID:31136966 |
| GO:0060073 | Micturition | Increases phenotype | PMID:29471072 |
| GO:0060179 | Male mating behavior | Affects phenotype | PMID:34060014 |
| GO:0060603 | Mammary gland duct morphogenesis | Increases phenotype | PMID:26518068 |
| GO:0060749 | Mammary gland alveolus development | Increases phenotype | PMID:26518068 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:34060014; PMID:34060014; PMID:34678318; PMID:34678318 |
| GO:0061744 | Motor behavior | Affects phenotype | PMID:30267645 |
| GO:0061827 | Sperm head | Affects phenotype | PMID:34678318 |
| GO:0070050 | Neuron cellular homeostasis | Affects phenotype | PMID:30497708 |
| GO:0070075 | Tear secretion | Increases phenotype | PMID:29471072 |
| GO:0070265 | Necrotic cell death | Affects phenotype | PMID:27737797; PMID:28549829; PMID:39419344; PMID:39832751 |
| GO:0070269 | Pyroptosis | Increases phenotype | PMID:26435000 |
| GO:0070328 | Triglyceride homeostasis | Decreases phenotype | PMID:29097212; PMID:31400774 |
| GO:0070374 | Positive regulation of erk1 and erk2 cascade | Affects phenotype | PMID:23416140 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:24793810; PMID:26435000; PMID:28433638; PMID:33839396; PMID:34060014; PMID:35448458; PMID:36341877; PMID:36811218; PMID:38849050 |
| GO:0071425 | Hematopoietic stem cell proliferation | Decreases phenotype | PMID:21987380 |
| GO:0071493 | Cellular response to uv-b | Affects phenotype | PMID:30765052 |
| GO:0071897 | Dna biosynthetic process | Increases phenotype | PMID:30981936 |
| GO:0072019 | Proximal convoluted tubule development | Decreases phenotype | PMID:32715474 |
| GO:0072215 | Regulation of metanephros development | Decreases phenotype | PMID:32715474 |
| GO:0072309 | Mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis | Decreases phenotype | PMID:32715474 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:23850137; PMID:29859868; PMID:30378422; PMID:32120800; PMID:32798940; PMID:35448458; PMID:35457321; PMID:36252918; PMID:36811218 |
| GO:0090200 | Positive regulation of release of cytochrome c from mitochondria | Increases phenotype | PMID:23416140 |
| GO:0090326 | Positive regulation of locomotion involved in locomotory behavior | Increases phenotype | PMID:28975519 |
| GO:0090398 | Cellular senescence | Increases phenotype | PMID:34830855 |
| GO:0090400 | Stress-induced premature senescence | Increases phenotype | PMID:21987380 |
| GO:0097153 | Cysteine-type endopeptidase activity involved in apoptotic process | Increases phenotype | PMID:36252918 |
| GO:0097225 | Sperm midpiece | Affects phenotype | PMID:34678318 |
| GO:0097511 | Dendritic cell dendrite | Decreases phenotype | PMID:23994500 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:32798940; PMID:33586219; PMID:34060014 |
| GO:0098508 | Endothelial to hematopoietic transition | Increases phenotype | PMID:31404653 |
| GO:0098598 | Learned vocalization behavior or vocal learning | Decreases phenotype | PMID:33540251 |
| GO:0098874 | Spike train | Increases phenotype | PMID:26409647 |
| GO:0106435 | Carboxylesterase activity | Decreases phenotype | PMID:35225412 |
| GO:0120193 | Tight junction organization | Affects phenotype | PMID:37263558 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:32017950 |
| GO:0140058 | Neuron projection arborization | Decreases phenotype | PMID:33011216 |
| GO:0160024 | Leydig cell proliferation | Decreases phenotype | PMID:38522820 |
| GO:1900182 | Positive regulation of protein localization to nucleus | Increases phenotype | PMID:32956863 |
| GO:1900745 | Positive regulation of p38mapk cascade | Affects phenotype | PMID:23416140 |
| GO:1901386 | Negative regulation of voltage-gated calcium channel activity | Increases phenotype | PMID:24913802; PMID:26187449 |
| GO:1901526 | Positive regulation of mitophagy | Increases phenotype | PMID:26070385 |
| GO:1901568 | Fatty acid derivative metabolic process | Affects phenotype | PMID:29097212 |
| GO:1901569 | Fatty acid derivative catabolic process | Decreases phenotype | PMID:26215119 |
| GO:1901610 | Positive regulation of vesicle transport along microtubule | Decreases phenotype | PMID:28600141 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:27268782; PMID:27268782; PMID:29667781; PMID:29667781; PMID:31823260 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Increases phenotype | PMID:23172834; PMID:26257840; PMID:31400774 |
| GO:1902177 | Positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | Affects phenotype | PMID:23416140 |
| GO:1902259 | Regulation of delayed rectifier potassium channel activity | Affects phenotype | PMID:26409647 |
| GO:1902632 | Positive regulation of membrane hyperpolarization | Increases phenotype | PMID:26409647 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:33839396 |
| GO:1903077 | Negative regulation of protein localization to plasma membrane | Increases phenotype | PMID:32956863 |
| GO:1903184 | L-dopa metabolic process | Affects phenotype | PMID:29859868 |
| GO:1903283 | Negative regulation of glutathione peroxidase activity | Increases phenotype | PMID:29667781; PMID:31823260 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:24979751; PMID:26435000; PMID:28887667; PMID:30758894; PMID:30835941; PMID:30981936; PMID:31152760 |
| GO:1903427 | Negative regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:35395341 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:26070385; PMID:29359425; PMID:36058312; PMID:26257840; PMID:29359425; PMID:29893964; PMID:29893964; PMID:33078895; PMID:32800223; PMID:35439518 |
| GO:1904457 | Positive regulation of neuronal action potential | Increases phenotype | PMID:26409647 |
| GO:1905051 | Regulation of base-excision repair | Affects phenotype | PMID:29359425 |
| GO:1905555 | Positive regulation of blood vessel branching | Increases phenotype | PMID:32526215 |
| GO:1905605 | Positive regulation of blood-brain barrier permeability | Increases phenotype | PMID:36167171; PMID:37263558 |
| GO:1905956 | Positive regulation of endothelial tube morphogenesis | Increases phenotype | PMID:32526215 |
| GO:1990138 | Neuron projection extension | Decreases phenotype | PMID:29859868 |
| GO:1990266 | Neutrophil migration | Increases phenotype | PMID:33524429 |
| GO:1990739 | Granulosa cell proliferation | Decreases phenotype | PMID:36769379 |
| GO:1990962 | Xenobiotic transport across blood-brain barrier | Increases phenotype | PMID:36167171 |
| GO:2000251 | Positive regulation of actin cytoskeleton reorganization | Increases phenotype | PMID:32956863 |
| GO:2000294 | Positive regulation of defecation | Increases phenotype | PMID:29471072 |
| GO:2000377 | Regulation of reactive oxygen species metabolic process | Affects phenotype | PMID:23416140 |
| GO:2000844 | Negative regulation of testosterone secretion | Increases phenotype | PMID:31400786; PMID:31823260 |
| GO:2000845 | Positive regulation of testosterone secretion | Decreases phenotype | PMID:23172834 |
| GO:2000865 | Negative regulation of estradiol secretion | Increases phenotype | PMID:26518068 |
| GO:2000871 | Negative regulation of progesterone secretion | Increases phenotype | PMID:26518068 |
| GO:2001170 | Negative regulation of atp biosynthetic process | Increases phenotype | PMID:28112198 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.